Serviços Personalizados
Journal
Artigo
Inglês (pdf)
Artigo em XML
Referências do artigo
Tradução automática
Enviar este artigo por emailIndicadores
Citado por SciELO 
Acessos
Links relacionados
Similares em
SciELO
Compartilhar
Permalink
Portuguese Journal of Dermatology and Venereology
versão impressa ISSN 2795-501Xversão On-line ISSN 2795-5001
Resumo
SOARES-CARDOSO, Sandra et al. Stevens-Johnson syndrome/toxic epidermal necrolysis overlap triggered by ethosuximide: a rare pediatric report. Port J Dermatol Venereol. [online]. 2023, vol.81, n.2, pp.124-128. Epub 27-Fev-2023. ISSN 2795-501X. https://doi.org/10.24875/pjdv.22000041.
Introduction:
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe and life-threatening mucocutaneous conditions characterized by fever and necrosis of the epidermis. Up to 90% of cases are drug-induced. Antiseizure drugs (ASD) are known to cause SJS, but only a very few ethosuximide-induced SJS cases have been reported in the literature.
Case presentation:
We report a case of ethosuximide-induced SJS/TEN overlap in a 4-year-old boy, confirmed by patch tests, with improvement with intravenous immunoglobulin (IVIG) and systemic corticosteroid therapy cycle.
Conclusion:
This case highlights the need to expand knowledge about the optimal treatment strategy for these rare conditions, in addition to supportive treatment.
Palavras-chave : Antiepileptic drug; Ethosuximide; Stevens-Johnson syndrome; Toxic epidermal necrolysis.
